[
  {
    "ts": null,
    "headline": "Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand",
    "summary": "MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.",
    "url": "https://finnhub.io/api/news?id=f06fd25b9cc5e3010600efc5a0d678e407fc4c807016b2e79700fba1aca57793",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772045700,
      "headline": "Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand",
      "id": 139225243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.",
      "url": "https://finnhub.io/api/news?id=f06fd25b9cc5e3010600efc5a0d678e407fc4c807016b2e79700fba1aca57793"
    }
  },
  {
    "ts": null,
    "headline": "FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand",
    "summary": "FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.",
    "url": "https://finnhub.io/api/news?id=ce84213d588bcac9a05fd09515c6da0e39b8e4c6516c810c0f1a87aa2a263987",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772045700,
      "headline": "FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand",
      "id": 139225242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.",
      "url": "https://finnhub.io/api/news?id=ce84213d588bcac9a05fd09515c6da0e39b8e4c6516c810c0f1a87aa2a263987"
    }
  },
  {
    "ts": null,
    "headline": "Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y",
    "summary": "AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.",
    "url": "https://finnhub.io/api/news?id=d0289cc2b2750d57d102dbd50f6938796e0d28f636611ff51d95e181b53e3d65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772041860,
      "headline": "Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y",
      "id": 139224045,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.",
      "url": "https://finnhub.io/api/news?id=d0289cc2b2750d57d102dbd50f6938796e0d28f636611ff51d95e181b53e3d65"
    }
  },
  {
    "ts": null,
    "headline": "Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y",
    "summary": "INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.",
    "url": "https://finnhub.io/api/news?id=7a6dbd7f72e2138c9fd0f38a2dfcc44dd76a8bbcb8c71ce1bfa6950eb3a8c185",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772041740,
      "headline": "Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y",
      "id": 139224046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.",
      "url": "https://finnhub.io/api/news?id=7a6dbd7f72e2138c9fd0f38a2dfcc44dd76a8bbcb8c71ce1bfa6950eb3a8c185"
    }
  },
  {
    "ts": null,
    "headline": "Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y",
    "summary": "ALC's Q4 EPS and revenues lag estimates, sending shares down 3%, even as sales increase 9% and 2026 guidance targets up to 7% growth.",
    "url": "https://finnhub.io/api/news?id=83724e1a28e95bb9949543387f1f55c2eecb29a23183ea210e11168bc6585491",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772023800,
      "headline": "Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y",
      "id": 139210774,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ALC's Q4 EPS and revenues lag estimates, sending shares down 3%, even as sales increase 9% and 2026 guidance targets up to 7% growth.",
      "url": "https://finnhub.io/api/news?id=83724e1a28e95bb9949543387f1f55c2eecb29a23183ea210e11168bc6585491"
    }
  },
  {
    "ts": null,
    "headline": "TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market",
    "summary": "Tempus AI posts Q4 revenue beat with 83% surge, but wider-than-expected loss and operating shortfall send shares down in after-hours trading.",
    "url": "https://finnhub.io/api/news?id=0b4a7916d46c5678cc41435e40ce95813c806d38dc98282b4b1bd6023b9ab250",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772022360,
      "headline": "TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market",
      "id": 139207744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Tempus AI posts Q4 revenue beat with 83% surge, but wider-than-expected loss and operating shortfall send shares down in after-hours trading.",
      "url": "https://finnhub.io/api/news?id=0b4a7916d46c5678cc41435e40ce95813c806d38dc98282b4b1bd6023b9ab250"
    }
  },
  {
    "ts": null,
    "headline": "Does Stronger Results And Specialty Pivot Reshape The Bull Case For Cardinal Health (CAH)?",
    "summary": "Cardinal Health recently declared a quarterly dividend of US$0.5107 per share, payable on April 15, 2026, to shareholders of record as of April 1, 2026, while also reporting stronger-than-expected quarterly results and lifting its fiscal 2026 profit outlook on the back of robust specialty-medicine demand. The company’s fresh Biosimilars Report, together with its ongoing pivot toward higher-margin specialty, at-home, and precision healthcare businesses, highlights how evolving treatment...",
    "url": "https://finnhub.io/api/news?id=7f292a2b25bb27d2c09106e768982af6d1979fd14fd1434f4dcb1f7ca5751fa6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771978911,
      "headline": "Does Stronger Results And Specialty Pivot Reshape The Bull Case For Cardinal Health (CAH)?",
      "id": 139203175,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health recently declared a quarterly dividend of US$0.5107 per share, payable on April 15, 2026, to shareholders of record as of April 1, 2026, while also reporting stronger-than-expected quarterly results and lifting its fiscal 2026 profit outlook on the back of robust specialty-medicine demand. The company’s fresh Biosimilars Report, together with its ongoing pivot toward higher-margin specialty, at-home, and precision healthcare businesses, highlights how evolving treatment...",
      "url": "https://finnhub.io/api/news?id=7f292a2b25bb27d2c09106e768982af6d1979fd14fd1434f4dcb1f7ca5751fa6"
    }
  }
]